Skip to main content
OpenTrials
Completed

NCT Number: NCT00919906

My Scrivener® - Measuring Effectiveness and Dose Response in Children

This study will assess whether a computer haptic peripheral device programmed to provide repetitive motion training is as effective as the same repetitive motion training provided by a human being.

Completed

Looking for future studies?

Notify Me

Key information

About this study

This study builds on a large body of neurological research that uses robot-guided repetitive motion training to induce neuroplasticity and improvements in upper extremity motor skills in adults and children. This research study is looking at handwriting, a fine-motor task that is used daily.

In our study, we want to see if 3-dimensional robotic-assisted repetitive motion training can be a safe and effective intervention for school-age children with fine motor deficits arising from several different impairment origins. Our research construct is: Legible handwriting = function of (tactile feedback, visual feedback, duration, and fine-motor control).

Independent variables:

  • Tactile feedback is a continuous variable of force-feedback measured in pounds of force.
  • Duration is a continuous variable measured in seconds and number of repetitions.
  • Visual feedback is the letter scribed on the paper.

Dependent variable:

  • Legible handwriting will be measured by scoring on the Test of Handwriting Skills and the Print Tool™ evaluation.
  • Fine motor deficit/control will be measured directly and objectively by quantifying the error between the desired scribing task and the actual scribing task.

The robotic device is an affordable (<$200) computer haptic (the Falcon(R)) that currently is approved by the FCC for home and office. It is *not* approved for medical use. This is an investigational, nonsignificant risk device.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Meet the following base prerequisites for writing: orientation to written language; eye-hand coordination, single handed utensil or tool manipulation (BAMF score >= 6), recognize all letters of the alphabet (unless the child has dyslexia).
  • Children have illegible printing for their grade, or legible printing but a speed less than the norms for their grade and sex.
  • Be able to grasp a pen.
  • Be able to speak and understand English.
  • Be able to follow instructions.
  • Be able to devote at least 20 minutes to the assigned tasks (short breaks will be allowed).
  • Be enrolled in school at grade K or above.
  • A score lower than 80% on the Print Tool™ or the Cursive Tool.

Exclusion criteria

  • Unable to pass the informed assent screener.
  • Unwilling to sign or mark the informed assent documents.
  • Uncontrolled spasticity.
  • A BAMF score lower than 6 (includes severe paralysis of the upper extremity).
  • Cerebral palsy other than hemiplegia cerebral palsy
  • Severe autism or intellectual disabilities that prevent productive interactions with the investigator

Treatment and study plan

My Scrivener(R)

Device

Twenty 20-minute sessions of the Handwriting Without Tears(R) instructional handwriting program, with substitution of hand-over-hand or self-generated repetitive motion writing by computer guided repetitive motion.

Other names: My Scrivener, Falcon, by Novint Technologies, Handwriting Without Tears

Primary outcomes

  1. Beery Motor Coordination Subtest

    Time frame: after 20 interventions

  2. Print Tool and Cursive Tool

    Time frame: after 20 interventions

  3. Deviations from desired 3-D writing path

    Time frame: after 5, 10, 15, 20 interventions

Secondary outcomes

  1. Brief Assessment of Fine Motor Skills

    Time frame: after 20 interventions

Sponsors and collaborators

Lead sponsor

Obslap Research LLC

Industry

Registry information

Important dates

Study start
2009
Primary completion
2010
Study completion
2010
First posted
Jun 12, 2009
Registry last updated
Oct 28, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.